← FDA Warning Letters

Bioptimal International

FDA Warning Letter · 2024-05-07 · "OHT2: Office of Cardiovascular Devices, Office of Product Evaluation and Quality"

Letter

Company
Bioptimal International
Posted Date
2024-05-07
Letter Issue Date
2024-04-03
Issuing Office
"OHT2: Office of Cardiovascular Devices, Office of Product Evaluation and Quality"

Subject

CGMP/QSR/Medical Devices/Adulterated

Source

Authoritative
FDA Warning Letters
Machine
JSON-LD · Markdown